Mary E. Vail

La Trobe University — Australia

Neuroscience · Life Sciences

13h-index816citations28works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Axon Guidance and Neuronal Signaling(13), Angiogenesis and VEGF in Cancer(8), Liver physiology and pathology(5), Cancer-related Molecular Pathways(4), HER2/EGFR in Cancer Research(4)

Publications28 total

Correction to: Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with 89Zr-labelled CI-8993
European Journal of Nuclear Medicine and Molecular Imaging·2024Open Access
Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with 89Zr-labelled CI-8993
European Journal of Nuclear Medicine and Molecular Imaging·2024· 3 citedOpen Access
Inhibition of EphA3 Expression in Tumour Stromal Cells Suppresses Tumour Growth and Progression
Cancers·2023· 11 citedOpen Access
Supplementary Methods, Tables 1 - 2, Figures 1 - 8 from Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment
2023Open Access
Data from Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment
2023Open Access
Supplementary Methods, Tables 1 - 2, Figures 1 - 8 from Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment
2023Open Access
Data from Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment
2023Open Access
Preferential Antibody and Drug Conjugate Targeting of the ADAM10 Metalloprotease in Tumours
Cancers·2022· 9 citedOpen Access
Eph Receptors in the Immunosuppressive Tumor Microenvironment
Cancer Research·2020· 56 citedOpen Access
Antibody Targeting of Eph Receptors in Cancer
Pharmaceuticals·2020· 37 citedOpen Access
An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth
The Journal of Experimental Medicine·2016· 73 citedOpen Access
Selective inhibition of notch signalling and cancer stem cells by an antibody targeting active ADAM10
European Journal of Cancer·2016
Abstract B04: A role for EphA3 in angiogenesis, in vivo and in vitro exploration
Cancer Research·2016
Hypoxia-Controlled EphA3 Marks a Human Endometrium-Derived Multipotent Mesenchymal Stromal Cell that Supports Vascular Growth
PLoS ONE·2014· 22 citedOpen Access
EphA3 biology and cancer
Growth Factors·2014· 80 cited
Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment
Cancer Research·2014· 81 cited
Antibodies binding the ADAM10 substrate recognition domain inhibit Eph function
Journal of Cell Science·2012· 43 citedOpen Access
Integrating Scientific Workflows and Large Tiled Display Walls: Bridging the Visualization Divide
2011· 2 cited
PTP1B regulates Eph receptor function and trafficking
The Journal of Cell Biology·2010· 64 citedOpen Access
An abstract virtual instrument system for high throughput automatic microscopy
Procedia Computer Science·2010· 7 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Peter W. Janes(15), Andrew M. Scott(15), Martin Lackmann(13), Linda Hii(9), Carmen Llerena(8), Slavisa Garic(8), Carmel Murone(6), April Tan(5), Mark Baer(5), Varghese Palath(5), Christopher Bebbington(5), Geoffrey Yarranton(5), Glenn A. Cartwright(5), Robert H. Pierce(4), Nelson Fausto(4), David Abramson(4), Rae H. Farnsworth(4), Lakmali Atapattu(4), Dimitar B. Nikolov(4), Degu Abebe(4)